Clinical Trial Update: ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ABX plus cisplatin to gemcitabine plus cisplatin in triple-negative breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• ABX
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED